HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Dysregulation of cyclin E gene expression in human cytomegalovirus-infected cells requires viral early gene expression and is associated with changes in the Rb-related protein p130.

Abstract
We have previously shown that many cell cycle regulatory gene products are markedly affected by infection of primary fibroblasts with human cytomegalovirus (HCMV) (F. M. Jault, J. M. Jault, F. Ruchti, E. A. Fortunato, C. Clark, J. Corbeil, D. D. Richman, and D. H. Spector, J. Virol. 69:6697-6704, 1995). One of these proteins, cyclin E, is a key determinant of cell cycle progression during G(1), and its mRNA levels are significantly increased in HCMV-infected fibroblasts (B. S. Salvant, E. A. Fortunato, and D. H. Spector, J. Virol. 72:3729-3741, 1998). To determine the molecular basis of this effect, we have examined the events that occur at the endogenous cyclin E promoter during the course of infection. In vivo dimethyl sulfate footprinting of the cyclin E promoter revealed several regions of protection and hypersensitivity that were unique to infected cells. In accord with this observation, we find that the virus-induced cyclin E transcripts initiate downstream of the start site identified in mock-infected cells, in regions where these newly appearing protected and hypersensitive sites occur. Viral gene expression is required for this induction. However, the viral immediate-early proteins IE1-72 and IE2-86, either alone or in combination, cannot induce expression of the endogenous cyclin E. The virus must progress past the immediate-early phase and express an early gene product(s) for activation of cyclin E expression. Moreover, IE1-72 does not appear to be required, as infection of cells with an HCMV mutant containing a deletion in the IE1-72 gene leads to full upregulation of cyclin E expression. Using electrophoretic mobility shift assays with infected cell extracts and a region of the cyclin E promoter that includes two previously defined E2F sites as the probe, we detected the appearance of an infection-specific banding pattern. One of the infection-specific bands contained the proteins E2F-4, DP-1, and p130, which were maintained in the infected cells as uniquely phosphorylated species. These results suggest that an altered E2F-4-DP-1-p130 complex along with viral early gene expression may play a role in the transcriptional regulation of cyclin E mRNA during HCMV infection.
AuthorsA K McElroy, R S Dwarakanath, D H Spector
JournalJournal of virology (J Virol) Vol. 74 Issue 9 Pg. 4192-206 (May 2000) ISSN: 0022-538X [Print] United States
PMID10756032 (Publication Type: Journal Article, Research Support, U.S. Gov't, P.H.S.)
Chemical References
  • Cyclin E
  • DNA-Binding Proteins
  • E2F4 Transcription Factor
  • IE1 protein, cytomegalovirus
  • IE2 protein, Cytomegalovirus
  • Immediate-Early Proteins
  • Membrane Glycoproteins
  • Phosphoproteins
  • Proteins
  • RBL2 protein, human
  • RNA, Messenger
  • Retinoblastoma-Like Protein p130
  • Trans-Activators
  • Transcription Factors
  • UL115 protein, Human herpesvirus 5
  • Viral Envelope Proteins
  • Viral Proteins
  • glycoprotein H, Cytomegalovirus
  • glycoprotein H, Human cytomegalovirus
  • glycoprotein O, cytomegalovirus
Topics
  • Binding Sites
  • Cells, Cultured
  • Cyclin E (genetics)
  • Cytomegalovirus (genetics, metabolism)
  • DNA Footprinting (methods)
  • DNA-Binding Proteins (metabolism)
  • E2F4 Transcription Factor
  • Humans
  • Immediate-Early Proteins (genetics, metabolism)
  • Membrane Glycoproteins
  • Phosphoproteins (metabolism)
  • Phosphorylation
  • Promoter Regions, Genetic
  • Proteins
  • RNA, Messenger
  • Retinoblastoma-Like Protein p130
  • Trans-Activators
  • Transcription Factors (metabolism)
  • Transcription, Genetic
  • Up-Regulation
  • Viral Envelope Proteins
  • Viral Proteins

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: